AAAAAA

   
Results: 1-17 |
Results: 17

Authors: SHEV S BJORKMAN P NORKRANS G FOBERG U FRYDEN A LINDH G LINDHOLM A WEILAND O WIDELL A
Citation: S. Shev et al., GBV-C HGV INFECTION IN HEPATITIS-C VIRUS-INFECTED DEFERRED SWEDISH BLOOD-DONORS/, Journal of medical virology, 54(2), 1998, pp. 75-79

Authors: REICHARD O NORKRANS G FRYDEN A BRACONIER JH SONNERBORG A WEILAND O
Citation: O. Reichard et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INTERFERON-ALPHA-2B WITH AND WITHOUT RIBAVIRIN FOR CHRONIC HEPATITIS-C, Lancet, 351(9096), 1998, pp. 83-87

Authors: REICHARD O NORKRANS G FRYDEN A BRACONIER JH ALAEUS A GLAUMANN H SCHVARCZ R SONNERBORG A WEJSTAL R WEILAND O
Citation: O. Reichard et al., INTERFERON-ALPHA AND RIBAVIRIN VERSUS INTERFERON-ALPHA ALONE AS THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Hepatology, 24(4), 1996, pp. 917-917

Authors: DUSHEIKO G MAIN J THOMAS H REICHARD O LEE C DHILLON A RASSAM S FRYDEN A REESINK H BASSENDINE M NORKRANS G CUYPERS T LELIE N TELFER P WATSON J WEEGINK C SILLIKENS P WEILAND O
Citation: G. Dusheiko et al., RIBAVIRIN TREATMENT FOR PATIENTS WITH CHRONIC HEPATITIS-C - RESULTS OF A PLACEBO-CONTROLLED STUDY, Journal of hepatology, 25(5), 1996, pp. 591-598

Authors: FOBERG U EKERMO B WIDELL A MATHIESEN U FRYDEN A
Citation: U. Foberg et al., HEPATITIS-C VIRUS TRANSMISSION, 1988-1991, VIA BLOOD COMPONENTS FROM DONORS SUBSEQUENTLY FOUND TO BE ANTI-HCV-POSITIVE, Scandinavian journal of infectious diseases, 28(1), 1996, pp. 21-26

Authors: SHEV S WIDELL A FOBERG U FRYDEN A HERMODSSON S LINDH G LINDHOLM A MANSSON S WEILAND O NORKRANS G
Citation: S. Shev et al., HCV GENOTYPES IN SWEDISH BLOOD-DONORS AS CORRELATED TO EPIDEMIOLOGY, LIVER-DISEASE AND HEPATITIS-C VIRUS-ANTIBODY PROFILE, Infection, 23(5), 1995, pp. 253-257

Authors: REICHARD O GLAUMANN H FRYDEN A NORKRANS G SCHVARCZ R SONNERBORG A YUN ZB WEILAND O
Citation: O. Reichard et al., 2-YEAR BIOCHEMICAL, VIROLOGICAL, AND HISTOLOGICAL FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS-C RESPONDING IN A SUSTAINED FASHION TO INTERFERON ALFA-2B TREATMENT, Hepatology, 21(4), 1995, pp. 918-922

Authors: KENYON RH NIKLASSON B JAHRLING PB GEISBERT T SVENSSON L FRYDEN A BENGTSSON M FOBERG U PETERS CJ
Citation: Rh. Kenyon et al., VIROLOGICAL INVESTIGATION OF A CASE OF SUSPECTED HEMORRHAGIC-FEVER, Research in virology, 145(6), 1994, pp. 397-406

Authors: DUSHEIKO G WEILAND O THOMAS H REICHARD O LEE C DHILLON A FRYDEN A REESINK H BASSENDINE M NORKRANS G CUYPERS H LELIE P MAIN J TELFER P RASSAM S WATSON J WEEGINK C
Citation: G. Dusheiko et al., RESULTS OF A PLACEBO-CONTROLLED STUDY OF RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 20(4), 1994, pp. 10000206-10000206

Authors: REICHARD O FOBERG U FRYDEN A MATTSSON L NORKRANS G SONNERBORG A WEJSTAL SR YUN ZB WEILAND O
Citation: O. Reichard et al., HIGH SUSTAINED RESPONSE RATE AND CLEARANCE OF VIREMIA IN CHRONIC HEPATITIS-C AFTER TREATMENT WITH INTERFERON-ALPHA(2B) FOR 60 WEEKS, Hepatology, 19(2), 1994, pp. 280-285

Authors: WIDELL A SHEV S MANSSON S ZHANG YY FOBERG U NORKRANS G FRYDEN A WEILAND O KURKUS J NORDENFELT E
Citation: A. Widell et al., GENOTYPING OF HEPATITIS-C VIRUS ISOLATES BY A MODIFIED POLYMERASE CHAIN-REACTION ASSAY USING TYPE-SPECIFIC PRIMERS - EPIDEMIOLOGIC APPLICATIONS, Journal of medical virology, 44(3), 1994, pp. 272-279

Authors: REICHARD O GLAUMANN H NORKRANS G WEJSTAL R FRYDEN A SCHVARCZ R WEILAND O
Citation: O. Reichard et al., HISTOLOGICAL OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS-C GIVEN A 60-WEEK INTERFERON ALFA-2B TREATMENT COURSE, Liver, 14(4), 1994, pp. 169-174

Authors: ROBERG M FORSBERG P FRYDEN A HEDERSTEDT B HYDEN D ODKVIST L
Citation: M. Roberg et al., LONG-TERM FINDINGS IN PATIENTS WITH FACIAL PALSY AND ANTIBODIES AGAINST BORRELIA-BURGDORFERI, Scandinavian journal of infectious diseases, 26(5), 1994, pp. 559-567

Authors: YUN ZB REICHARD O CHEN M LUNDEBERG J NORKRANS G FRYDEN A SONNERBORG A WEILAND O
Citation: Zb. Yun et al., SERUM HEPATITIS-C VIRUS-RNA LEVELS IN CHRONIC HEPATITIS-C - IMPORTANCE FOR OUTCOME OF INTERFERON ALFA-2B TREATMENT, Scandinavian journal of infectious diseases, 26(3), 1994, pp. 263-270

Authors: HYDEN D ROBERG M FORSBERG P FRIDELL E FRYDEN A LINDE A ODKVIST L
Citation: D. Hyden et al., ACUTE IDIOPATHIC PERIPHERAL FACIAL PALSY - CLINICAL, SEROLOGICAL, ANDCEREBROSPINAL-FLUID FINDINGS AND EFFECTS OF CORTICOSTEROIDS, American journal of otolaryngology, 14(3), 1993, pp. 179-186

Authors: SHEV S FOBERG U FRYDEN A HERMODSSON S LINDH G LINDHOLM A MANSSON AS VONSYDOW M WEILAND O WIDELL A NORKRANS G
Citation: S. Shev et al., 2ND-GENERATION HEPATITIS-C ELISA ANTIBODY TESTS CONFIRMED BY THE 4-ANTIGEN RECOMBINANT IMMUNOBLOT ASSAY CORRELATE WELL WITH HEPATITIS-C VIREMIA AND CHRONIC LIVER-DISEASE IN SWEDISH BLOOD-DONORS, Vox sanguinis, 65(1), 1993, pp. 32-37

Authors: MATHIESEN UL KARLSSON E FOBERG U FRYDEN A FRANZEN L WIDELL A BODEMAR G
Citation: Ul. Mathiesen et al., ALSO WITH A RESTRICTIVE TRANSFUSION POLICY, SCREENING WITH 2ND-GENERATION ANTI-HEPATITIS-C VIRUS ENZYME-LINKED-IMMUNOSORBENT-ASSAY WOULD HAVE REDUCED POSTTRANSFUSION HEPATITIS-C AFTER OPEN-HEART-SURGERY, Scandinavian journal of gastroenterology, 28(7), 1993, pp. 581-584
Risultati: 1-17 |